INSIGHTS ON LIQUID DOSE MANUFACTURING
-
![GettyImages-182145359 combination products]( "The Challenges Of Developing Combination Products")
The Challenges Of Developing Combination ProductsExamine the regulatory complexity of combination products and learn how holistic development strategies, early equipment decisions, and representative clinical supply reduce risk and costs.
-
![Emergent BioSolutions]( "Aseptic Filling Solution Enhances Sterility Assurance for Pharma Manufacturer")
Aseptic Filling Solution Enhances Sterility Assurance for Pharma ManufacturerEmergent BioSolutions upgraded its Winnipeg site with the Cytiva SA25 aseptic filling workcell to improve sterility assurance, product flexibility, and regulatory compliance for CGT manufacturing.
-
![afton jan 26 ff]( "Afton Scientific Capabilities Update January 2026: Fill/Finish")
Afton Scientific Capabilities Update January 2026: Fill/FinishHere, Michael Dunn outlines our current available capacity, including RABS operations, alongside the commissioning of a new Annex 1–compliant isolator filling line and expanded QC capabilities to ensure reliable, scalable execution.
-
![GettyImages-1790844511-assay-laboratory-machine-plate]( "Three Key Actions To Minimize Dead Volumes")
Three Key Actions To Minimize Dead VolumesMinimizing liquid dead volume helps labs conserve costly reagents and scarce samples while boosting assay throughput. Learn how advanced liquid level detection technologies are driving efficiency.
-
Vaccine Fill Line Operations11/24/2025
Learn how adopting a harmonized, risk-based validation strategy across global sites can reduce operational readiness timelines and drive improvements in equipment effectiveness and regulatory compliance
-
Streamline Global Regulatory Submissions5/21/2026
Discover a more streamlined approach with one accountable partner supporting regulatory submissions globally.
-
Unlock A Faster, More Efficient Route To Commercialization7/2/2026
Streamline commercialization with a variable-dose, disposable pen injector platform. Ideal for GLP-1 therapies, biosimilars, and generics, it combines intuitive patient handling with market entry.
-
Protecting Your Drug Product5/13/2026
With patient lives depending on every dose, even minor vulnerabilities in containment or delivery systems can have serious consequences for product integrity and patient outcomes.
-
Success Factors For Pre-Filled Syringe CMO Selection9/1/2026
Within the past few decades, there has been a steady increase in the use of pre-filled syringes (PFS) for parenteral administration of biologics, biosimilars, and other drugs.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
![syringe vaccine]( "Syringe Forming Lines")
Syringes are complex products that require an extremely precise forming process: Stevanato Group syringe manufacturing lines include several specifications, which are normally optional, such as servomotors for controlling the most critical manufacturing phases (cone forming, total length) and flow meters for automatically regulating the burners.
-
![BD_Physioject_IMG_3332-450x300]( "BD Physioject™ Disposable Autoinjector")
BD Physioject™ Disposable Autoinjector offers a proven, user-friendly platform for self-injection, enhancing patient comfort, safety, and adherence across multiple chronic disease treatments globally.
-
![Cozzoli Ophthalmic Monoblock Filling Line, Model RFPCquad]( "Ophthalmic Monoblock Filling Line")
Used Cozzoli ophthalmic monoblock filling line, with Cozzoli intermittent motion monoblock rotary filler, plugger, capper, torquer, model RFPCquad, with (4) head filling station, speeds up to 180 bottles/minute, fills of 5, 10 and 15 mL bottles, vibrating bowl feeders for plugs and caps, for 12.4 and 19 mm plugs, 20 mm caps, with model VU36 bottle unscrambler feeder, with bottle elevator, model AT42, 42" discharge accumulation table, built 2020, FAT performed end of 2020, unit installed 2022. With Unused model S250 Labeler.
-
![ASEPTiCell ScreenShot 8]( "Aseptic And Syringe Filling Equipment For Contract Manufacturers (CDMOs)")
Having the right balance of capacity and capabilities in all market conditions is the struggle that Contract Manufacturer Organizations face daily. Add to it the cost and complexity of maintaining a suitable parenteral manufacturing facility, the risks can be high. With constantly evolving parenteral market needs, having flexibility while achieving high utilization is key to long term success. To support these challenges, AST’s line of aseptic and syringe filling and closing machines provide adaptive fill-finish capabilities to ensure that any contract manufacturing organization has the right capabilities for any vial, syringe filling or cartridge application.
-
![Sterile Fill Finish Capacity sized]( "Sterile Fill/Finish Capability")
Through a science-led approach and extensive experience in product development, our team can support you with aseptic and terminally sterilized small volume liquids, as well as ocular and pulmonary delivery.
